J. Kavanagh

发表

Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?

N. Laube, J. Kavanagh, 2006, The Journal of urology.

The association of different urinary proteins with calcium oxalate hydromorphs. Evidence for non-specific interactions.

B. Heywood, J. Kavanagh, R. Walton, 2005, Biochimica et biophysica acta.

The probability of obtaining complex kinetic curves for enzyme mechanisms with cubic terms in the pseudo-steady state rate equations.

W. Bardsley, J. Kavanagh, R. Wood, 1982, Journal of theoretical biology.

In vitro calcium oxalate crystallisation methods

J. Kavanagh, 2006, Urological Research.

Methods for the study of calcium oxalate crystallisation and their application to urolithiasis research.

J. Kavanagh, 1992, Scanning microscopy.

The response of seven prostatic fluid components to prostatic disease.

J. Kavanagh, C. Darby, C. Costello, 1982 .

Does fish oil benefit stone formers?

N. Blacklock, R. Green, J. Kavanagh, 1993, The Journal of urology.

Urinary Tract Stone Disease

G. Preminger, J. Kavanagh, P. Rao, 2011 .

Inhibition of growth of primary human prostate cells by phytoestrogens.

J. Kavanagh, J. Hempstock, N. George, 1999, Journal of medicinal food.

Growth inhibition of prostate cell lines in vitro by phyto-oestrogens.

J. Kavanagh, J. Hempstock, N. George, 1998, British journal of urology.

Kinetics of circulating TNF-alpha and TNF soluble receptors following surgery in a clinical model of sepsis.

J. Kavanagh, P. N. Rao, D. Neilson, 1996, Cytokine.

A critical appraisal of the hypothesis that urine is a saturated equilibrium with respect to stone‐forming calcium salts

J. Kavanagh, 2001, BJU international.

Calcium oxalate crystallization kinetics at different concentrations of human and artificial urine, with a constant calcium to oxalate ratio

J. Kavanagh, P. Rao, L. Jones, 1999, Urological Research.

The density and protein content of calcium oxalate crystals precipitated from human urine: a tool to investigate ultrastructure and the fractional volume occupied by organic matrix.

B. Heywood, J. Kavanagh, R. Walton, 2003, Journal of structural biology.

Calcium oxalates grown in human urine under different batch conditions

B. Heywood, J. Kavanagh, R. Walton, 2005 .

Methods for Measuring Crystallization in Urolithiasis Research: Why, How and When?

H. Tiselius, R. Ryall, D. Kok, 2001, European Urology.

Calcium oxalate crystallization kinetics studied by oxalate-induced turbidity in fresh human urine and artificial urine.

J. Kavanagh, P. Rao, L. Jones, 2000, Clinical science.

Reverse engineering the kidney: modelling calcium oxalate monohydrate crystallization in the nephron

A. Borissova, G. E. Goltz, J. P. Kavanagh, 2010, Medical & Biological Engineering & Computing.

Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.

J. Kavanagh, P. Rao, K. Chow, 2007, The Journal of urology.

Physicochemical Aspects of Uro-crystallization and Stone Formation

J. Kavanagh, 2010 .

A nidus, crystalluria and aggregation: key ingredients for stone enlargement

J. Kavanagh, P. Rao, N. Saw, 2008, Urological Research.

Calcium Oxalate Supersaturation of Urine: Which Factors should be Measured?

J. Kavanagh, P. Rao, 1994 .

Enlargement of a lower pole calcium oxalate stone: a theoretical examination of the role of crystal nucleation, growth, and aggregation.

J. Kavanagh, 1999, Journal of endourology.

Crystallization kinetics of calcium oxalate in fresh, minimally diluted urine: comparison of recurrent stone formers and healthy controls in a continuous mixed suspension mixed product removal crystallizer.

J. Garside, N. Blacklock, J. Kavanagh, 1993, The Journal of urology.

Does sucrose damage kidneys?

N. Blacklock, J. Kavanagh, M. Li, 1986, British journal of urology.

Calcium Oxalate Crystallisation Kinetics and the Effects of Calcium and γ‐Carboxyglutamic Acid

E. Faragher, J. Garside, N. Blacklock, 1990 .

A small-scale continuous mixed suspension mixed product removal crystallizer

J. Garside, J. Kavanagh, S. Nishio, 1991 .

Citrate inhibits growth of residual fragments in an in vitro model of calcium oxalate renal stones.

J. Dixon, S. Gilpin, J. Kavanagh, 2004, Kidney international.

A stone farm: development of a method for simultaneous production of multiple calcium oxalate stones in vitro

J. Dixon, S. Gilpin, J. Kavanagh, 2004, Urological Research.

Crystal Growth and Nucleation Rates for Calcium Oxalate in 92% Fresh Urine in a Continuous Crystalliser

J. Garside, N. Blacklock, J. Kavanagh, 1994 .

Enlargement of calcium oxalate stones to clinically significant size in an in‐vitro stone generator

J. Kavanagh, P. Rao, K. Ananth, 2002, BJU international.

Supersaturation and renal precipitation: the key to stone formation?

J. Kavanagh, 2006, Urological Research.

Calcium oxalate crystallisation kinetics and the effects of calcium and gamma-carboxyglutamic acid.

E. Faragher, J. Garside, N. Blacklock, 1990, British journal of urology.

Pyrophosphate in Synovial Fluid and Urine and its Relationship to Urinary Risk Factors for Stone Disease

T. Helliwell, J. Dutton, J. Kavanagh, 1992, Annals of clinical biochemistry.

Isocitric and citric acid in human prostatic and seminal fluid: Implications for prostatic metabolism and secretion

J. Kavanagh, 1994, The Prostate.

Sodium, potassium, calcium, magnesium, zinc, citrate and chloride content of human prostatic and seminal fluid.

J. Kavanagh, J P Kavanagh, 1985, Journal of reproduction and fertility.

The purification and preliminary investigation of fumarase, peroxidase, diamine oxidase and adenosine deaminase from human seminal plasma [proceedings].

M. Crabbe, J. Kavanagh, 1977, Biochemical Society transactions.

Deviations from Michaelis-Menten kinetics. The possibility of complicated curves for simple kinetic schemes and the computer fitting of experimental data for acetylcholinesterase, acid phosphatase, adenosine deaminase, arylsulphatase, benzylamine oxidase, chymotrypsin, fumarase, galactose dehydrogen

P. Leff, W. Bardsley, J. Kavanagh, 1980, The Biochemical journal.

Levamisole and other diamine oxidase inhibitors as inhibitors of sperm motility.

W. Bardsley, J. Kavanagh, R. Brightwell, 1981, Archives of andrology.

The identity of the acid and alkaline phosphatases of human seminal plasma.

W. Bardsley, J. Kavanagh, 1979, Journal of reproduction and fertility.

Do stone formers have lower urinary fibrinolytic activity than controls?

D. Barker, N. Blacklock, B. Margetts, 1990, British journal of urology.

Should Hypercalciuria be Redefined

J. Kavanagh, G. Mobb, P. Rao, 1994 .

Urogastrone-epidermal growth factor concentrations in prostatic fluid of normal individuals and patients with benign prostatic hypertrophy.

N. Blacklock, J. Kavanagh, R. C. Richards, 1986, Clinical science.

The response of seven prostatic fluid components to prostatic disease.

J. Kavanagh, C. Darby, C. Costello, 1982, International journal of andrology.

Zinc in post prostatic massage (VB3) urine samples: A marker of prostatic secretory function and indicator of bacterial infection

J. Kavanagh, C. Darby, C. Costello, 2004, Urological research.

Ratio of post-prostatic massage urinary zinc concentration to initial urinary zinc concentration. An improved method of assessing prostatic function.

N. Blacklock, J. Kavanagh, E. Farragher, 1988, British Journal of Urology.

Thyrotropin(TSH) Should Replace the RIA Methodin the Clinical

M. Navarro, L. Juan, M. Bonnín, 1986 .

Zinc binding properties of human prostatic tissue, prostatic secretion and seminal fluid.

J. Kavanagh, 1983, Journal of reproduction and fertility.

The interrelationships between acid phosphatase, aminopeptidase, diamine oxidase, citric acid, β‐glucuronidase, pH and zinc in human prostatic fluid

J. Kavanagh, C. Darby, 1982 .

Measurement of citrate in urine using liquid chromatography tandem mass spectrometry: comparison with an enzymatic method

B. Keevil, L. Owen, J. Kavanagh, 2005, Annals of clinical biochemistry.

A multicentre prospective study of prostatic volume in asymptomatic men in various continents

N. Blacklock, J. Kavanagh, A. Ferreira, 1997, Prostate Cancer and Prostatic Diseases.

Ethical Issues in Plant Relocation

J. Kavanagh, 1982 .

Creatine kinase and ATPase in human seminal fluid and prostatic fluid.

J. Kavanagh, C. Darby, 1983, Journal of reproduction and fertility.